Medx Health Corp Stock Price To Earnings To Growth
| MDXHF Stock | USD 0.0008 0.00 0.00% |
Fundamental analysis of MedX Health allows traders to better anticipate movements in MedX Health's stock price by examining its financial health and performance throughout various phases of its business cycle.
MedX |
MedX Health Corp Company Price To Earnings To Growth Analysis
MedX Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, MedX Health Corp has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
MedX Fundamentals
| Return On Asset | -2.31 | |||
| Operating Margin | (7.84) % | |||
| Current Valuation | 6.88 M | |||
| Shares Outstanding | 183.8 M | |||
| Shares Owned By Insiders | 2.00 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | (6.46) X | |||
| Price To Sales | 10.56 X | |||
| Revenue | 563.1 K | |||
| Gross Profit | 268.11 K | |||
| EBITDA | (4.49 M) | |||
| Net Income | (5.32 M) | |||
| Cash And Equivalents | 40.49 K | |||
| Total Debt | 2.39 M | |||
| Current Ratio | 0.19 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (4.52 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 15 | |||
| Beta | 1.0 | |||
| Market Capitalization | 6.87 M | |||
| Total Asset | 731.06 K | |||
| Z Score | -18.6 | |||
| Net Asset | 731.06 K |
About MedX Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedX Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedX Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedX Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in MedX Pink Sheet
MedX Health financial ratios help investors to determine whether MedX Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedX with respect to the benefits of owning MedX Health security.